Skip to main content
Have a personal or library account? Click to login
Hypertensive Disorders of Pregnancy Cover

References

  1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: Chronic hypertension in pregnancy. Obstet Gynecol. 2019 Jan;133(1):e26-e50. doi: 10.1097/AOG.0000000000003020
  2. Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012 Feb;206(2):134.e1-8. doi: 10.1016/j.ajog.2011.10.878
  3. CDC.gov [Internet]. Washington DC: US Department of Health and Human Services; c2024. CDC press release: Hypertensive disorders in pregnancy affect 1 in 7 hospital deliveries; 2022 Apr 28 [cited 2024 Jan 30]. Available from: https://www.cdc.gov/media/releases/2022/p0428-pregnancy-hypertension.html
  4. Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD. Births: Final data for 2001. Natl Vital Stat Rep. 2002 Dec 18;51(2):1-102. PMID: 12596439
  5. ACC.org [Internet]. Washington, DC: American College of Cardiology; c2024. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults; 2017 [cited 2024 Jan 23]. Available from: https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2017/Guidelines_Made_Simple_2017_HBP.pdf
  6. Damron DP. Chronic hypertension in pregnancy. Obstet Gynecol. 2002 Dec;100(6): 1358. doi: 10.1016/s0029-7844(02)02500-0
  7. Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PloS One. 2013 May;8(5):e62140. doi: 10.1371/journal.pone.0062140
  8. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med. 2007 Nov;52(11):1046-1051. PMID: 18161404
  9. Van Gelder MMHJ, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell A. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case–control study. BJOG. 2015 Jun;122(7):1002-9. doi: 10.1111/1471-0528.13138
  10. Ratnapalan S, Koren G. Taking ACE inhibitors during pregnancy. Is it safe?. Can Fam Physician. 2002 Jun;48(6):1047-9. PMID: 12113190
  11. Morgan JL, Nelson DB, Roberts SW, Wells CE, McIntire DD, Cunningham FG. Association of baseline proteinuria and adverse outcomes in pregnant women with treated chronic hypertension. Obstet Gynecol. 2016 Aug;128(2):270-276. doi: 10.1097/AOG.0000000000001517
  12. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000 Jul;118(1):214-27. doi: 10.1378/chest.118.1.214
  13. Bannan LT, Beevers DG, Wright N. ABC of blood pressure reduction. Emergency reduction, hypertension in pregnancy, and hypertension in the elderly. Br Med J. 1980 Oct 25;281(6248):1120-2. doi: 10.1136/bmj.281.6248.1120
  14. Tita AT, Szychowski JM, Boggess K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295
  15. ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy. Obstet Gynecol. 2018 Jul;132(1):e44-e52. doi: 10.1097/AOG.0000000000002708
  16. Bregand-White JM, Kominiarek MA, Hibbard JU. Hypertension and patterns of induced labor at term. Pregnancy Hypertens. 2017 Oct;10:57-63. doi: 10.1016/j.preghy.2017.06.003
  17. Ananth CV, Brandt JS, Hill J, et al. Historical and recent changes in maternal mortality due to hypertensive disorders in the United States, 1979 to 2018. Hypertension 2021 Nov;78(5):1414-1422. doi: 10.1161/HYPERTENSIONAHA.121.17661
  18. Leonard SA, Formanowski BL, Phibbs CS, et al. Chronic Hypertension in Pregnancy and Racial–Ethnic Disparities in Complications. Obstet Gynecol. 2023 Oct 1;142(4):862-871. doi: 10.1097/AOG.0000000000005342
  19. Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010 Aug 21;376(9741):631-44. doi: 10.1016/S0140-6736(10)60279-6
  20. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013 Nov 7;347:f6564. doi: 10.1136/bmj.f6564
  21. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, No. 222. Obstet Gynecol. 2020 Jun;135(6):e237-e260. doi: 10.1097/AOG.0000000000003891
  22. Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol. 2009 Jun;33(3):166-72). doi: 10.1053/j.semperi.2009.02.0030
  23. Noraihan MN, Sharda P, Jammal AB. Report of 50 cases of eclampsia. J Obstet Gynaecol Res. 2005 Aug;31(4):302-9. doi: 10.1111/j.1447-0756.2005.00292.x
  24. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998 Nov;179(5):1359-75. doi: 10.1016/s0002-9378(98)70160-7
  25. Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol. 2003 Feb;162(2):637-43. doi: 10.1016/S0002-9440(10)63857-6
  26. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001 May;184(6):1249-50. doi: 10.1067/mob.2001.112906
  27. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CWG. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol. 2003 Aug;59(2):153-60. doi: 10.1016/s0165-0378(03)00044-5
  28. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol. 1991 Oct;98(10):973-9. doi: 10.1111/j.1471-0528.1991.tb15334.x
  29. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New Engl J Med. 2006 Sep 7;355(10):992-1005. doi: 10.1056/NEJMoa055352
  30. Fetal Growth Restriction: ACOG Practice Bulletin, No. 227. 2021 Feb 1;137(2):e16-e28. doi: 10.1097/AOG.0000000000004251
  31. Lee LO, Bateman BT, Kheterpal S, et al. Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2017 Jun;126(6):1053-1063. doi: 10.1097/ALN.0000000000001630
  32. Blue NR, Murray-Krezan C, Drake-Lavelle S, et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial. Am J Obstet Gynecol. 2018 Jun;218(6):616.e1-616.e8. doi: 10.1016/j.ajog.2018.02.016
  33. Grandi SM, Vallée-Pouliot K, Reynier P, et al. Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease. Paediatr Perinat Epidemiol. 2017 Sep:;31(5):412-421. doi: 10.1111/ppe.12388
  34. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011 Jun 21;123(24):2856-69. doi: 10.1161/CIRCULATIONAHA.109.853127
  35. Chen CW, Jaffe IZ, Karumanchi SA. Pre-eclampsia and cardiovascular disease. Cardiovasc Res. 2014 Mar 15;101(4):579-86. doi: 10.1093/cvr/cvu018
  36. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005 Nov 19;366(9499):1797-803. doi: 10.1016/S0140-6736(05)67726-4
  37. O’Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003 May;14(3):368-74. doi: 10.1097/00001648-200305000-00020
  38. Ray JG. Dysmetabolic syndrome, placenta-mediated disease and future risk of cardiovascular disease. Fetal Matern Med Rev. 2004 Oct 19;15(3):231-246. doi: 10.1017/S0965539504001287
  39. Jomini V, Oppliger-Pasquali , Wietlisbach V, et al. Contribution of major cardiovascular risk factors to familial premature coronary artery disease: the GENECARD project. J Am Coll Cardiol. 2002 21;40(4):676-84. doi: 10.1016/s0735-1097(02)02017-x
  40. McNicoll S, Latour Y, Rondeau C, Bouthillier D, Davignon J, Genest, J Jr. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II. Can J Cardiol. 1995 Feb;11(2):109-16. PMID: 7866933. doi: 10.1016/0021-9150(94)93131-3
DOI: https://doi.org/10.14797/mdcvj.1305 | Journal eISSN: 1947-6108
Language: English
Page range: 4 - 12
Submitted on: Oct 25, 2023
Accepted on: Feb 5, 2024
Published on: Mar 14, 2024
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2024 Courtney Newman, Victoria Petruzzi, Pedro T. Ramirez, Christopher Hobday, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.